CorNova

About:

CorNova develops endovascular products designed to integrate new technologies into existing products and procedures.

Website: http://www.cornova.com

Top Investors: Implant Sciences, CardioTech

Description:

CorNova® is a developer of next-generation endovascular products designed to integrate new technologies into existing products and procedures, resulting in better patient outcomes without added procedure time and patient risk. The FiberHalo™ stent deployment catheter will enable the physician to deploy a stent and measure in-stent lumen area during the procedure. The FiberHalo™ post-dilatation catheter will enable the physician to correct for any under-expansion and also measure post-dilatation results. CorNova is also developing a pre-dilatation version of the FiberHalo™, which will enable the physician to determine likelihood of mechanical failure of stent deployment, allowing for better decision making. CorNova has recently received CE certification on the Valecor Platinum™ stent (a bare metal stent with a pure platinum surface for increased biocompatibility and designed to reduce arterial injury), which has shown superior performance and anti-restenosis properties compared to current bare metal stents.